The Research and Development team at Combined Therapeutics focuses on advancing innovative therapeutic solutions by optimizing mRNA formulations and processes. This team conducts preclinical studies to evaluate the efficacy and safety of next-generation mRNA technologies, bridging the gap between scientific discovery and practical application to enhance patient outcomes.